EXT] Test 2

Thanks ... no longer yelling into the abyss __

On 3/27/20, 10:18 PM, "Antibody Discussion Forum on behalf of Bover,Laura"
<email obscured> on behalf of <email obscured>> wrote:

    I see it

    Laura Bover, PhD
    Professor
    Director Monoclonal Antibody Core Facility
    University of Texas M.D.Anderson Cancer Center
    Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
    Member of the Scientific Review Committee 2 (former Clinical Research
Committee 2)
    Member of the Steering Committee of the Immunology Program GSBS
    Immunology Department/ Genomics Medicine Department
    7455 Fannin St Room 1SCR4.2021
    Houston- TX 77054
    T  713-563-3301 <tel:713-563-3301>
    F 713-563-3276 <tel:713-563-3276>
    <email obscured>

    In order to continue obtaining Core support in a challenging environment,
it is crucial that our users acknowledge the following grants in all
publications (see following text).  Thank you!
     “We acknowledge the UT-MDACC Monoclonal Antibodies Core facility,
supported in part by CCSG grant number P30 CA016672.”



    On 3/27/20, 9:17 PM, "Antibody Discussion Forum on behalf of Frances
Weis-Garcia" <email obscured> on behalf of
<email obscured>> wrote:

        WARNING: This email originated from outside of MD Anderson. Please
validate the sender's email address before clicking on links or attachments as
they may not be safe.

        Test 2
        If anyone sees this please reply back so I know
        I am having problems with the system

        ――
        View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5qnWcfLL9MMUyBsHOHnqgE__;!!PfbeBCCAmug!woh-BILXGFc_UKRJgoKugU3EZkmrNu3FJVCQVwL8glCL-2Hrmmm5zLG2UQOTICnH$
        Leave group <email obscured>?Subject=Unsubscribe




    The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.

    ――
    View topic http://list.abrf.org/r/topic/5qRdmxSVG8Veg5SY2DtRLh
    Leave group <email obscured>?Subject=Unsubscribe

Me too

Sent from my iPhone

> On Mar 27, 2020, at 10:18 PM, Bover,Laura <email obscured>> wrote:
>
> I see it
>
> Laura Bover, PhD
> Professor
> Director Monoclonal Antibody Core Facility
> University of Texas M.D.Anderson Cancer Center
> Associate member of The University of Texas Graduate School of Biomedical
Sciences at Houston
> Member of the Scientific Review Committee 2 (former Clinical Research
Committee 2)
> Member of the Steering Committee of the Immunology Program GSBS
> Immunology Department/ Genomics Medicine Department
> 7455 Fannin St Room 1SCR4.2021
> Houston- TX 77054
> T  713-563-3301 <tel:713-563-3301>
> F 713-563-3276 <tel:713-563-3276>
> <email obscured>
>
> In order to continue obtaining Core support in a challenging environment, it
is crucial that our users acknowledge the following grants in all publications
(see following text).  Thank you!
> “We acknowledge the UT-MDACC Monoclonal Antibodies Core facility, supported
in part by CCSG grant number P30 CA016672.”
>
>
>
> On 3/27/20, 9:17 PM, "Antibody Discussion Forum on behalf of Frances
Weis-Garcia" <email obscured> on behalf of
<email obscured>> wrote:
>
>   WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
>
>   Test 2
>   If anyone sees this please reply back so I know
>   I am having problems with the system
>
>   ――
>   View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/5qnWcfLL9MMUyBsHOHnqgE__;!!PfbeBCCAmug!woh-BILXGFc_UKRJgoKugU3EZkmrNu3FJVCQVwL8glCL-2Hrmmm5zLG2UQOTICnH$
>   Leave group <email obscured>?Subject=Unsubscribe
>
>
>
>
> The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
>
> ――
> View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_5qRdmxSVG8Veg5SY2DtRLh&d=DwIFaQ&c=lb62iw4YL4RFalcE2hQUQealT9-RXrryqt9KZX2qu2s&r=0t4gvG5S4xJ4qh8QKA3DA2OcWGulGoAxklm2L3plckU&m=YtVlLNDm4Kr8SjjhFlw-lf_V1xHmQML5xZ64dTtIZnQ&s=ym_JkqIbp4Xlddf_6fK9orCi8Ao4kBSdxQMNf-rw7NM&e=

> Leave group <email obscured>?Subject=Unsubscribe
>